Mycobacterial infection after renal transplantation in a Western population

Transplant Infectious Disease

Volumn 5, Issue 1, 2003, Pages 9-15

  Vandermarllere, A ^a   Van Audenhove, A ^a   Peetermans, W E ^b   Vanrenterghem, Y ^a   Maes, Bart ^a,b  

^a Department of Nephrology ^*  (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Corticosteroids; Immunosuppressive therapy; Transplantation; Tuberculosis

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; ETHAMBUTOL; INTERLEUKIN 2 RECEPTOR ANTIBODY; ISONIAZID; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; ORTHOCLONE; PREDNISOLONE; RAPAMYCIN; RIFAMPICIN; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; ZENAPEX;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; BELGIUM; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG PULSE THERAPY; DRUG RESPONSE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT INFECTION; RISK FACTOR; SKIN TUBERCULOSIS; TENDON; TUBERCULOUS ARTHRITIS; TUBERCULOUS PLEURISY;

EID: 0038275914     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3062.2003.00010.x     Document Type: Article

References (17)

1. SINGH N, PATERSON DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998: 27: 1266-1277.
2. FISHMAN JA, RUBIN RH. Medical progress: infection in organ-transplant recipients. N Engl J Med 1998: 338: 1741-1751.
3. QUNIBI WY, AL-SIBAI MB, TAHER S, et al. Mycobacterial infection after renal transplantation - report of 14 cases and review of the literature. Q J Med 1990: 282: 1039-1060.
4. HIGGINS RM, CAHN AP, PORTER D, et al. Mycobacterial infections after renal transplantation. Q J Med 1991: 286: 145-153.
5. VACHHARAJANI T, ABREO K, PHADKE A, OZA U, KIRPALANI A. Diagnosis and treatment of tuberculosis in hemodialysis and renal transplant patients. Am J Nephrol 2000: 20: 273-277.
6. BARBER T, SUGAR AS. Mycobacteriosis and nocardiosis in the immunocompromised host. In: RUBIN RH, YOUNG LS, eds. Clinical Approach to Infection in the Compromised Host (3rd edn). New York: Plenum Medical Books Company, 1994: 239-274.
7. GRANGE JM, GIRLING DJ, DAVIES PDO. Disease caused by environmental mycobacteria. In: WEATHERALL DJ, LEDINGHAM JGG, WARRELL DA, eds. Oxford Textbook of Medicine. Oxford, UK: Oxford University Press, 1996: 664-667.
8. WAUTERS A, PEETERMANS W, DE MOOR B, et al. Evaluation of tuberculin skin testing in hemodialysis patients. Abstract ASN October 2002 (A588).
9. SAKHUJA V, JHA V, VARMA PP, JOSHI K, CHUGH KS. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996: 61: 211-215.
10. BIZ E, PEREIRA CAP, MOURA LAR, et al. The use of cyclosporin modifies the clinical and histopathological presentation of tuberculosis after renal transplantation. Rev Inst Med Trop S Paulo 2000: 42: 225-230.
11. KALENDER B, APAYDIN S, ALTIPARMAK MR, et al. Opportunistic pulmonary infection after renal transplantation. Transplant Proc 2000: 32: 563-565.
12. NAQVI A, AKHTAR F, NAQVI R, et al. Problems of diagnosis and treatment of tuberculosis following renal transplantation. Transplant Proc 1997: 29: 3051-3052.
13. TARAMELLI D, MALABARBA MG, BASILICO N, SALA G, MATTINA R, COCUZZA C. Effects of pidotimod on macrophage functions in methylprednisolone-treated mice. Arzneimittelforschung 1994: 44:1425-1430.
14. STOKVIS H, LANGERMANS JA, DE BACKER VLEDDER E, VAN DER HULST ME, VAN FURTH R. Hydrocortisone treatment of BCG-infected mice impairs the activation and enhancement of antimicrobial activity of peritoneal macrophages. Scand J Immunol 1992: 36: 299-305.
15. BLOTTA MH, DEKRUYFF RH, UMETSU DT. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J Immunol 1997: 158: 5589-5595.
16. APAYDIN S, ALTIPARMAK MR, SERDENGEÇTI K, ATAMAN R, ÖZTÜRK R, EREK E. Mycobacterium tuberculosis infections after renal transplantation. Scand J Infect Dis 2000: 32: 501-505.
17. ANONYMOUS. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society, MMWR 2000: 49: 1-51.